These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20660853)

  • 21. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ;
    Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411
    [No Abstract]   [Full Text] [Related]  

  • 22. [BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation].
    Jernberg T; Boman K; James S; Lindahl B; Stridsberg M; Swedberg K; Venge P
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1289-92, 1295. PubMed ID: 16708856
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF).
    Bayes-Genis A
    Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 25. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
    Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Natriuretic peptides as cardiac markers in clinical practice].
    Veien KT; Jensen JK; Hildebrandt P; Gøtze JP; Nielsen OW; Køber L
    Ugeskr Laeger; 2010 Jul; 172(30):2111-6. PubMed ID: 20654278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Troughton RW; Richards AM; Yandle TG; Nicholls G
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232832
    [No Abstract]   [Full Text] [Related]  

  • 31. [A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients].
    Di Lenarda A
    G Ital Cardiol (Rome); 2016 Jan; 17(1):48-50. PubMed ID: 26901258
    [No Abstract]   [Full Text] [Related]  

  • 32. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 34. [Natriuretic cardiac hormones. Clinical use in heart failure].
    Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J
    Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102
    [No Abstract]   [Full Text] [Related]  

  • 35. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute dyspnea: what is the diagnostic role of B-type natriuretic peptide?].
    Sarasin FP
    Rev Med Suisse; 2005 Aug; 1(29):1888-91. PubMed ID: 16152876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited value of brain natriuretic peptide as a prognostic marker in acute heart failure--a meta-analysis.
    Binder A; Seropian IM; Kontos MC; Van Tassell BW; Biondi-Zoccai GG; Abbate A
    Int J Cardiol; 2010 Dec; 145(3):540-1. PubMed ID: 20541821
    [No Abstract]   [Full Text] [Related]  

  • 40. Heart failure and B-type natriuretic protein.
    Hoyne J
    Clin Lab Sci; 2009; 22(4):233-9. PubMed ID: 19967919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.